• All sections
  • C - Chemistry; metallurgy
  • C07D - Heterocyclic compounds
  • C07D 211/14 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom

Patent holdings for IPC class C07D 211/14

Total number of patents in this class: 377

10-year publication summary

41
21
26
26
22
26
30
23
25
10
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
5080
8
Incyte Corporation
918
7
Nocion Therapeutics, Inc.
45
7
Janssen Pharmaceutica N.V.
3839
6
Incyte Holdings Corporation
609
6
Toyama Chemical Co., Ltd.
114
6
University of Pittsburgh - Of the Commonwealth System of Higher Education
2912
6
Massachusetts Institute of Technology
9795
5
BASF SE
19740
4
Centre National de La Recherche Scientifique
9632
4
Immunomet Therapeutics Inc.
30
4
Modernatx, Inc.
1181
4
Taisho Pharmaceutical Co., Ltd.
844
4
Anji Pharmaceuticals Inc.
38
4
Libra Therapeutics, Inc.
5
4
Boehringer Ingelheim International GmbH
4629
3
Chevron U.S.A. Inc.
3774
3
President and Fellows of Harvard College
5792
3
JSR Corporation
2476
3
Bioprojet
52
3
Other owners 283